• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Wandercraft’s self-balancing Eve exoskeleton begins US launch

Wandercraft’s self-balancing Eve exoskeleton begins US launch

September 21, 2026 By Conor Hale

This is a Wandercraft marketing image that shows the self-balancing Eve allowing the wearer to stand hands-free.
The self-balancing Eve allows the wearer to stand hands-free. [Photo courtesy of Wandercraft]
After securing an FDA clearance last month, Wandercraft is taking its personalized exoskeleton for a walk with its commercial debut.

The self-balancing Eve system can help wheelchair users with spinal cord injuries walk upright via its hand controls, and can then stay standing hands-free without crutches or a walker to allow the wearer to carry objects or open doors.

The company describes Eve as the first FDA-cleared device in its category, and it is now available to adults with spinal cord injuries at any neurological level. After a clinical evaluation and trial run, the exoskeleton is personally fitted and manufactured, followed by an individualized training program with the Wandercraft team and its partners before delivery.

“FDA clearance showed that Eve was ready to move forward. Today is about making it a reality for the people we built it for,” said Wandercraft co-founder and CEO Matthieu Masselin. The company raised the curtain last week at a Sept. 17 event in New York City with the United Spinal Association.

“We have spent years developing the robotics, but our breakthroughs only matter when we’re able to better connect people to the world around them. That’s why we built an infrastructure that supports people every step of the way, from evaluation and fitting to reimbursement, training, and ongoing service,” Masselin added.

The company said that personal exoskeletons are covered by Medicare as custom-fitted orthoses, and that it is working to secure reimbursements from private insurance providers.

Eve’s FDA clearance in August was supported by a three-site clinical trial in the greater NYC area, with participants reporting improvements in health status, psychological well-being and endurance during daily activities.

The company previously obtained multiple agency green lights for its Atalante X self-balancing exoskeleton, designed for gait training in rehabilitation. Meanwhile, a paraplegic person wearing an early prototype for Eve participated in the torch relay for the 2024 Olympic Games.

Last year saw developer Lifeward launch its latest ReWalk 7 exoskeleton for people with spinal cord injuries, while German Bionic debuted its Exia lift-assistance device for industrial use.

Filed Under: Business/Financial News, Featured, News Well, Robotic-Assisted Tagged With: exoskeletons, spinal cord injury, wandercraft

More recent news

  • Wandercraft’s self-balancing Eve exoskeleton begins US launch
  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy